Puretech founded entity sonde health raises $19.25 million series b for voice-based health monitoring

Boston--( business wire )--puretech health plc (nasdaq: prtc, lse: prtc) (“puretech” or the “company”), a clinical-stage biotherapeutics company, noted today that its founded entity, sonde health, a health technology company committed to bringing accessible health monitoring to everyone, announced it has raised a $19.25 million series b investment round with a strong group of financial and strategic investors.
PRTC Ratings Summary
PRTC Quant Ranking